Point in time view as at 06/11/2023.
The Medicines for Human Use (Clinical Trials) Regulations 2004, Paragraph 3 is up to date with all changes known to be in force on or before 10 March 2025. There are changes that may be brought into force at a future date. Changes that have been made appear in the content and are referenced with annotations.
3.—(1) In the Medicines (Exemption from Licences) (Special Cases and Miscellaneous Provisions) Order 1972 F1, article 4 shall be amended as follows.U.K.
(2) In paragraph (1)—
(a)for “sections 7, 31(2) and 32” substitute “ sections 7 and 32 ”;
(b)in subparagraph (a), omit “a clinical trial, or, as the case may be,”.
(3) In paragraph (2)—
(a)in subparagraph (i)—
(i)in paragraph (a), omit “a clinical trial, or, as the case may be,”,
(ii)in paragraph (b), omit “clinical trial or”;
(b)in subparagraph (iii)—
(i)omit “the clinical trial or, as the case may be,”,
(ii)omit the words from “the doctor or dentist” to “as the case may be,”;
(c)in subparagraph (iv)—
(i)omit the words from “that the doctor or dentist” to “as the case may be,”,
(ii)omit the words “the trial, or, as the case may be”.
(4) Omit paragraph (3).
Textual Amendments
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
